Melissa Weber


How Important Is CYP2D6 Status in Hormone-Sensitive Cancers?

December 09, 2010

In recent years, scientists discovered that an enzyme called CYP2D6 could possibly predict whether a patient would respond to the drug. Small studies aimed at confirming the predictive link, however, have been consistently inconsistent.

Afinitor Boosts Effectiveness of Hormonal Therapy

December 09, 2010

Adding Afinitor, an mTOR inhibitor, to tamoxifen helped women with metastatic breast cancer live about four months longer without their disease getting worse, according to a study presented Thursday at SABCS.